H. CORWIN HINSHAW, M.D., PH.D., F.A.C.P.; WILLIAM H. FELDMAN, D.V.M., M.S.; KARL H. PFUETZE, M.D.
The enthusiasm for chemotherapy of clinical tuberculosis which has been expressed by some authors of articles in newspapers and popular magazines is not as yet shared by most physicians who are utilizing these preparations, although it is widely felt that steady progress is being maintained. Premature dissemination of unreliable information to patients and their relatives can do serious harm if it serves to discourage acceptance of effective conventional treatment, including sanatorium care and collapse therapy. It appears presently important to provide in one article, in a widely circulated medical journal, up-to-date, authentic information on chemotherapy of tuberculosis. With one exception,1
H. CORWIN HINSHAW, WILLIAM H. FELDMAN, KARL H. PFUETZE. PRESENT STATUS OF CHEMOTHERAPY IN TUBERCULOSIS(PRESENT STATUS OF CHEMOTHERAPY IN TUBERCULOSIS*). Ann Intern Med. 1945;22:696–703. doi: 10.7326/0003-4819-22-5-696
Download citation file:
Published: Ann Intern Med. 1945;22(5):696-703.
Infectious Disease, Mycobacterial Infections.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use